Blood is a peer-reviewed medical journal published by the American Society of Hematology. It was established by William Dameshek in 1946. The journal changed from semimonthly to weekly publication at the start of 2009. It covers clinical and basic research in all areas of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology.
The British Journal of Cancer is a twice-monthly professional medical journal owned by Cancer Research UK, published on their behalf by Springer Nature's Nature Research.
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 44.544 as reported by Clarivate in its 2020 Journal Citation Reports.
Allied Academies is a reportedly fraudulent corporation chartered under the laws of North Carolina. Its postal address is in London, United Kingdom. It presents itself as an association of scholars, with supporting and encouraging research and the sharing and exchange of knowledge as its stated aims. The organization consists of 30 affiliate academies, which provide awards to academics and publish academic journals both online and in hard copy for members. Since 2015 the organization has been listed on Jeffrey Beall's list of "potential, possible, or probable predatory scholarly open-access publishers". It is in a partnership with OMICS Publishing Group which uses its website and logo. In 2018, OMICS owner Srinubabu Gedela declared that he had informed the Nevada court that Allied Academies was a subsidiary of OMICS International. During a conference in 2018, they falsely listed a prominent chemist among its organizing committee who had not agreed to this and was not affiliated with Allied Academies.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
The Journal of the American College of Cardiology is a peer-reviewed medical journal covering all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the-art papers, review articles, and editorials interpreting and commenting on the research presented, published by the American College of Cardiology.
The Journal of the National Cancer Institute (JNCI) is a peer-reviewed medical journal covering research in oncology that was established in August 1940. It is published monthly by Oxford University Press and is edited by Patricia A. Ganz. It was merged with Cancer Treatment Reports in January 1988. JNCI used to be the official journal of the National Cancer Institute (NCI); however, in 1996, the NCI and JNCI agreed to grow apart. Over the next five years, JNCI became independent of the NCI.
Oncology Reports is a peer-reviewed medical journal of oncology published monthly by Spandidos Publications. The editor-in-chief is Demetrios A. Spandidos. The journal was established in 1994.
Oral Oncology is a monthly peer-reviewed medical journal published by Elsevier covering research about head and neck cancer. It is the official journal of the International Association of Oral Pathologists, the European Association of Oral Medicine, and the International Academy of Oral Oncology.
Lung Cancer is a peer-reviewed medical journal published by Elsevier originally published on behalf of the International Association for the Study of Lung Cancer. As of 2015, it is published on behalf of the International Lung Cancer Consortium, the European Thoracic Oncology Platform, and the British Thoracic Oncology Group. It includes original research and review articles of relevance to lung cancer.
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang. The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").
The Journal of Oncology Pharmacy Practice is a peer-reviewed academic journal that publishes papers bi-monthly in the field of Pharmacology. The journal's editor is Barry R. Goldspiel. It has been in publication since 1995 and is currently published by SAGE Publications in association with the International Society of Oncology and Pharmacy Practitioners.
The Clinical Journal of Oncology Nursing is a bimonthly peer-reviewed nursing journal covering oncology nursing. It was established in 1997 and is published by the Oncology Nursing Society. The editor-in-chief is Ellen Carr.
Annals of Surgical Oncology is a peer-reviewed medical journal published by Springer International Publishing on behalf of the Society of Surgical Oncology. It is an official journal of the Society of Surgical Oncology, and the American Society of Breast Surgeons. The editor-in-chief is Kelly M. McMasters.
The Journal of Radiation Research is a bimonthly peer-reviewed scientific journal covering research on radiation and oncology. It was established in 1960 and is published by Oxford University Press. Its editor-in-chief is Kenshi Komatsu.
Future Oncology is a peer-reviewed medical journal established in 2005 and published by Future Medicine. It covers all aspects of oncology. The editors-in-chief are Ron Allison and Jackson Orem.
The Journal of Cancer Research and Clinical Oncology is a monthly peer-reviewed medical journal covering oncology. It was established in 1903 under the name Zeitschrift für Krebsforschung, and changed its name to Zeitschrift für Krebsforschung und klinische Onkologie in 1971. The journal obtained its current name in 1979. It is published by Springer Science+Business Media under a hybrid publishing model and the editor-in-chief is Klaus Hoffken.
JAMA Oncology is a monthly peer-reviewed medical journal published by the American Medical Association. It covers all aspects of medical oncology, radiation oncology, and surgical oncology, as well as subspecialties. The journal was established in 2015. The founding editor-in-chief is Mary L. Disis.
Tumor Biology is a bimonthly peer-reviewed open access medical journal covering clinical and experimental oncology. It was established in 1980 as Oncodevelopmental Biology and Medicine, obtaining its current name in 1984. It is owned by the International Society of Oncology and BioMarkers, of which it is the official journal. Originally published by Karger Publishers, it moved to Springer Science+Business Media beginning in 2010. In December 2016, the journal moved again, this time to SAGE Publications. The editor-in-chief is Magdalena Chechlinska. According to the Journal Citation Reports, the journal has a 2016 impact factor of 3.650.
The European Journal of Oncology Nursing is a peer-reviewed medical journal covering cancer research of direct relevance to patient care, nurse education, management, and policy development. It is published by Elsevier. The journal was established in 1997, with Alison Richardson as its founding editor-in-chief. It is the official journal of the European Oncology Nursing Society and its current editor-in-chief is Alex Molassiotis.
